Cgmp-pde inhibitors for the treatment of erectile dysfunction

Details Cgmp-pde inhibitors for the treatment of erectile dysfunction Cgmp-pde inhibitors for the treatment of erectile dysfunction

A - Human Necessities

61

K

A61K 31/522 (2006.01) A61K 31/4164 (2006.01) A61K 31/44 (2006.01) A61K 31/498 (2006.01) A61K 31/4985 (2006.01) A61K 31/505 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01) A61P 15/10 (2006.01)

Patent

CA 2203379

Compounds which are selective inhibitors of cGMP PDE are useful in the treatment of erectile dysfunction (impotence) in male animals, including man.

Ces composés qui sont des inhibiteurs sélectifs des cGMP PDE (guanosine 3',5'-monophosphate cyclique phosphodiestérase) sont utiles dans le traitement du dysfonctionnement érectile (impuissance) chez les animaux mâles, notamment chez l'homme.

Affiliated with

Also associated with

Rating

Cgmp-pde inhibitors for the treatment of erectile dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cgmp-pde inhibitors for the treatment of erectile dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cgmp-pde inhibitors for the treatment of erectile dysfunction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1622387